Sagimet Biosciences | 8-K: Current report
Sagimet Biosciences | 8-K: Sagimet Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates
Sagimet Biosciences | 10-Q: Quarterly report
Sagimet Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Chauche Thierry
Sagimet Biosciences | 3: Initial statement of beneficial ownership of securities-Officer Chauche Thierry
Sagimet Biosciences | 8-K: Current report
Sagimet Biosciences | ARS: Annual Report to Security Holders
Sagimet Biosciences | DEFA14A: Others
Sagimet Biosciences | DEF 14A: Definitive information statements
Sagimet Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Walbert Timothy P
Sagimet Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Hoelscher Paul W.
Sagimet Biosciences | 3: Initial statement of beneficial ownership of securities-Director Walbert Timothy P
Sagimet Biosciences | 3: Initial statement of beneficial ownership of securities-Director Hoelscher Paul W.
Sagimet Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Happel David
Sagimet Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Sagimet Biosciences | 10-K: Annual report
Sagimet Biosciences | 8-K: Current report
Sagimet Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(2.444%),Abigail P. Johnson(2.444%)
Sagimet Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-New Enterprise Associates 13, L.P.(6.6%),NEA Partners 13, L.P.(6.6%), etc.
Sagimet Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Baker Bros. Advisors LP(6.8%),Baker Bros. Advisors (GP) LLC(6.8%), etc.
No Data